Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial.

导出 LinkOut

翻译打印收藏纠错

作者： Debu,Tripathy ; Sara M,Tolaney ; Andrew D,Seidman ; Carey K,Anders ; Nuhad,Ibrahim ; Hope S,Rugo ; Chris,Twelves ; Véronique,Diéras ; Volkmar,Müller ; Yining,Du ; Sue L,Currie ; Ute,Hoch ; Mary,Tagliaferri ; Alison L,Hannah ; Javier,Cortés ; ATTAIN Investigators

主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);脑肿瘤(Brain Neoplasms);乳腺肿瘤(Breast Neoplasms);女(雌)性(Female);人类(Humans);中年人(Middle Aged);聚乙烯二醇类(Polyethylene Glycols)

DOI 10.1001/jamaoncol.2022.0514

PMID 35552364

发布时间 2024-08-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JAMA oncology

2022年8卷7期

1047-1052页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial.

JAMA oncology

相似文献

JAMA oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial.

JAMA oncology

相似文献

JAMA oncology

相关期刊

检索历史清除